J Dermatolog Treat:红霉素凝胶联合或不联合醋酸锌治疗轻中度寻常痤疮的疗效评估

2021-05-09 MedSci原创 MedSci原创

红霉素是一种有效的外用抗生素,用于治疗轻中度炎症性寻常痤疮,特别是青春期的丘疹性痤疮以及成年女性的丘疹-脓疱性痤疮。红霉素是一种大环内酯类抗生素,长期以来一直作为外用药物治疗痤疮。锌是一种金属元素,对

红霉素是一种有效的外用抗生素,用于治疗轻中度炎症性寻常痤疮,特别是青春期的丘疹性痤疮以及成年女性的丘疹-脓疱性痤疮。红霉素是一种大环内酯类抗生素,长期以来一直作为外用药物治疗痤疮。锌是一种金属元素,对痤疮丙酸杆菌具有抑菌活性。将锌与红霉素联合使用可以减少抗生素的耐药性,并增加皮肤对抗生素的吸收。近日,一项双盲研究中,研究人员评估了红霉素(2% w/v)与醋酸锌(1.2% w/v)作为"外用凝胶"和红霉素(2% w/v)凝胶单独用于治疗轻中度炎症性寻常痤疮的疗效,研究结果已发表于J Dermatolog Treat。

研究纳入了102名13-25岁的患者,分为两组:A组接受红霉素治疗,B组在3周内接受红霉素与醋酸锌外用凝胶。基线以及治疗第一、第二和第三周分别评估痤疮分级和粉刺、丘疹和脓疱的皮损。

 

结果显示,红霉素治疗(含醋酸锌)凝胶比红霉素(单用)凝胶在减少痤疮皮损数量和痤疮严重程度方面更有效,两组的皮损数量和痤疮严重程度在第三周治疗结束时都明显减少(P < .001)。

综上所述,该研究结果表明,红霉素联合或不联合醋酸锌治疗在临床上都是有效的,两种配方都能使痤疮分级以及炎症和非炎症皮损数量显著减少(P < .000)。

 

原始出处:

 

Mohammad Sadegh Sayyafan, et al.,  Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris. J Dermatolog Treat. 2020 Nov;31(7):730-733. doi: 10.1080/09546634.2019.1606394.  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-11 lishizhe
  5. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-10 桃花依旧笑春风

    很棒

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1915711, encodeId=f4ab1915e1120, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Mon Aug 02 12:32:50 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749224, encodeId=02ad1e4922471, content=<a href='/topic/show?id=bc0fe7197d0' target=_blank style='color:#2F92EE;'>#红霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77197, encryptionId=bc0fe7197d0, topicName=红霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e02f36248491, createdName=wolongzxh, createdTime=Sat May 29 22:32:50 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796278, encodeId=26641e9627813, content=<a href='/topic/show?id=cf2a1e7818c' target=_blank style='color:#2F92EE;'>#TREAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17781, encryptionId=cf2a1e7818c, topicName=TREAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Fri Oct 01 07:32:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461074, encodeId=623114610e476, content=<a href='/topic/show?id=de4331310a4' target=_blank style='color:#2F92EE;'>#凝胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Tue May 11 11:32:50 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964164, encodeId=96af9641647d, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/8a254f37b7344cf590ed5fcaf561ab3d/0f9b6c151b8b47179cda6bab405f39ba.jpg, createdBy=24d23511050, createdName=桃花依旧笑春风, createdTime=Mon May 10 06:42:41 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032902, encodeId=a7971032902b6, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Sun May 09 23:32:50 CST 2021, time=2021-05-09, status=1, ipAttribution=)]
    2021-05-09 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0

相关资讯

阿奇霉素治疗未足月胎膜早破的新方案

未足月胎膜早破(PROM)可引起1/4—1/3的早产。其发病原因通常是未知的,但可能与感染、遗传变异或其它因素有关。未临产前,抗生素的使用可减少绒毛膜羊膜炎的发生率,延长孕周和减少胎儿和新生儿并发症。 根据美国妇产科学院(ACOG)的推荐,PROM应接受氨苄青霉素和红霉素的治疗(48小时的肠外抗生素紧随其后5天口服阿莫西林和红霉素)。尽管,临床医生常用阿奇霉素代替红霉素,来降低成本。但是

CMAJ:心脏病患者慎吃抗生素

口服红霉素与安体舒通(一种利尿剂,用于治疗心脏衰竭)联合用药会加倍老年患者猝死的风险。最近一份来自加拿大的研究报告得出此结论。 由加拿大多伦多圣迈克尔医院的Tony Antoniou博士领导的团队分析了66岁以上的患者从1994年到2011年使用安体舒通治疗的检测结果。该研究囊括的患者数量超过20万,其中1万多名患者出现了猝死,另外有349名患者在服用抗生素之后的14天内病逝。 

AIM:克拉霉素或红霉素升高他汀药物毒性反应风险

  美国一项研究表明,在老年人群中,他汀类与克拉霉素或红霉素同时应用可升高他汀类药物的毒性反应风险。论文发表于《内科学年鉴》[Ann Intern Med 2013;158(12):869]。   此项基于人群的队列研究纳入了年龄大于65岁的他汀类持续应用者,并对同时应用克拉霉素(72591例)或红霉素(3267例)的受试者和同时应用阿奇霉素者(68478例)进行了

6省药店大涨价,红霉素眼膏等涨10倍

药店廉价药、紧缺药或将彻底和“观众”告别,“几毛钱”的时代一去不返!

Ann Intern Med:克拉霉素或红霉素升高他汀药物毒性反应风险

  美国一项研究表明,在老年人群中,他汀类与克拉霉素或红霉素同时应用可升高他汀类药物的毒性反应风险。论文发表于《内科学年鉴》。   此项基于人群的队列研究纳入了年龄大于65岁的他汀类持续应用者,并对同时应用克拉霉素(72591例)或红霉素(3267例)的受试者和同时应用阿奇霉素者(68478例)进行了比较。主要转归为抗生素处方开具30天内因横纹肌溶解而住院治疗。   结果显示,阿托伐他汀(